EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of a novel quantitative multiparametric MR sequence for radiation therapy treatment response assessment

Yuhao Yan, R Adam Bayliss, Adam R Burr, Andrew M Baschnagel, Brett A Morris, Florian Wiesinger, Jose de Arcos Rodriguez, Carri K Glide-Hurst

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.70274 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Yuhao Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Radiosurgery, Brain Neoplasms, Head and Neck Neoplasms, Phantoms, Imaging. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiparametric MRI has shown great promise to derive multiple quantitative imaging biomarkers for treatment response assessment.

Purpose

To evaluate a novel deep‐learning‐enhanced MUlti‐PArametric MR sequence (DL‐MUPA) for treatment response assessment for brain metastases patients treated with stereotactic radiosurgery (SRS) and head‐and‐neck (HN) cancer patients undergoing conventionally fractionation adaptive radiation therapy.

Methods

DL‐MUPA derives quantitative T1 and T2 relaxation time maps from a single 4–6‐min scan denoised via DL method using least‐squares dictionary fitting. Longitudinal phantom benchmarking was performed on a NIST‐ISMRM phantom over 1 year. In patients, longitudinal DL‐MUPA data were acquired on a 1.5T MR‐simulator, including pretreatment (PreTx) and every ∼3 months after SRS (PostTx) in brain, and PreTx, mid‐treatment and 3 months PostTx in HN. Delta analysis was performed calculating changes of mean T1 and T2 values within gross tumor volumes (GTVs), residual disease (RD, HN), parotids, and submandibular glands (HN) for treatment response assessment. Uninvolved normal tissues (normal appearing white matter in brain, masseter in HN) were evaluated for within‐subject repeatability.

Results

Phantom benchmarking revealed excellent inter‐session repeatability (coefficient of variation < 0.9% for T1, < 6.6% for T2), suggesting reliability for longitudinal studies with systematic bias adjustment. Uninvolved normal tissue suggested acceptable within‐subject repeatability in the brain |ΔT1 mean | < 36 ms (4.9%), |ΔT2 mean | < 2 ms (6.1%) and HN |ΔT1 mean | < 69 ms (7.0%), |ΔT2 mean | < 4 ms (17.8%) with few outliers. In brain, remarkable changes were noted in a resolved metastasis (4‐month PostTx ΔT1 mean = 155 ms (13.7%)) and necrotic settings (ΔT1 mean = 214‐502 ms (17.6‐39.7%), ΔT2 mean = 7‐41 ms (8.7‐41.4%), 6‐month to 3‐month PostTx). In HN, two base of tongue tumors exhibited T2 enhancement (PostTx GTV ΔT2 mean > 7 ms (12.8%), RD ΔT2 mean > 10 ms (18.1%)). A case with nodal disease resolved PostTx (GTV ΔT1 mean = ‐541 ms (‐39.5%), ΔT2 mean = ‐24 ms (‐32.7%), RD ΔT1 mean = ‐400 ms (‐29.2%), ΔT2 mean = ‐25 ms (‐35.3%)). Parotids (PostTx ΔT1 mean > 82 ms (12.4%), ΔT2 mean > 6 ms (13.4%)) and submandibular glands (PostTx ΔT1 mean > 135 ms (14.6%), ΔT2 mean > 17 ms (34.5%)) adjacent to gross disease exhibited enhancement while distant organs remained stable.

Conclusions

Preliminary results suggest promise of DL‐MUPA for treatment response assessment and highlight potential endpoints for functional sparing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryBrain NeoplasmsHead and Neck NeoplasmsPhantoms, ImagingMultiparametric Magnetic Resonance ImagingRadiotherapy Planning, Computer-AssistedDeep LearningImage Processing, Computer-AssistedHumansRadiotherapy, Intensity-ModulatedRadiotherapy DosageMaleFemale

Stichwörter der Autor:innen

multi‐parametric MRIquantitative MRItreatment response assessment

Autor:innen und Institutionen

  • Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • GE HealthCare, Munich, Germany.
  • GE HealthCare, Little Chalfont, Buckinghamshire, UK.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Yan, Y., Bayliss, R. A., Burr, A. R., Baschnagel, A. M., Morris, B. A., Wiesinger, F., Rodriguez, J. A., & Glide-Hurst, C. K. (2025). Evaluation of a novel quantitative multiparametric MR sequence for radiation therapy treatment response assessment. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70274

Vancouver

Yan Y, Bayliss RA, Burr AR, Baschnagel AM, Morris BA, Wiesinger F, et al. Evaluation of a novel quantitative multiparametric MR sequence for radiation therapy treatment response assessment. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70274

BibTeX
@article{Yan2025,
  author = {Yan, Yuhao and Bayliss, R Adam and Burr, Adam R and Baschnagel, Andrew M and Morris, Brett A and Wiesinger, Florian and Rodriguez, Jose de Arcos and Glide-Hurst, Carri K},
  title = {Evaluation of a novel quantitative multiparametric MR sequence for radiation therapy treatment response assessment},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70274}
}
Kostenlos starten →